Mirum Pharmaceuticals, Inc. (MIRM) Minute Stock Prediction

About:

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company’s lead product candidate is Maralixibat, an investigational oral drug that is in Phase 3 clinical trial for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It is also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. The company was incorporated in 2018 and is headquartered in Foster City, California.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

68

Address:

Mirum Pharmaceuticals, Inc. 950 Tower Lane Suite 1050 Foster City CA 94404 United States

Website:

Home

Phone:

650-667-4085